These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21180309)

  • 1. Non cardiac effects of beta blockers.
    Wander GS; Kaushal S
    Indian Heart J; 2010; 62(2):154-7. PubMed ID: 21180309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications for beta blockers besides coronary disease and arterial hypertension].
    Vetterl F
    Soins Cardiol; 1985; (28-29):25-30. PubMed ID: 2865813
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenoceptor blocking drugs in therapy.
    Deshmukh YA
    Q Med Rev; 1986 Jul; 37(3):1-29. PubMed ID: 2884692
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications.
    Frishman W; Silverman R
    Am Heart J; 1979 Jul; 98(1):119-31. PubMed ID: 36741
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):746-61. PubMed ID: 6115528
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical review of beta-blockers in anxiety.
    Kelly D
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):259-66. PubMed ID: 6108580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta blockers between tremor and vibrato].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1986 Apr; 130(17):765-6. PubMed ID: 2872599
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockade--selection and use.
    Heikkilä J; Jounela A; Katila M; Luomanmäki K; Frick MH
    Ann Clin Res; 1979 Dec; 11(6):267-89. PubMed ID: 44825
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-blockers in glaucoma].
    Enache D
    Oftalmologia; 1992; 36(2):101-9. PubMed ID: 1356020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peri-operative cardiac assessment & rationale for use of beta-blockers.
    Chopra HK; Sambi RS; Krishna CK; Parasher SK; Gupta R; Singh M; Garg V
    Indian Heart J; 2010; 62(2):158-67. PubMed ID: 21180310
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-blockers and portal hypertension: in search of the ideal].
    Bandi JC; Mastai R
    Acta Gastroenterol Latinoam; 1998; 28(4):313-4. PubMed ID: 10347688
    [No Abstract]   [Full Text] [Related]  

  • 12. [beta-Blockers as adjuvant therapy in delirium tremens (author's transl)].
    Holzbach E
    MMW Munch Med Wochenschr; 1980 May; 122(22):837-40. PubMed ID: 6104786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic properties and therapeutic use of beta adrenergic receptor blocking drugs].
    Shanks RG
    Medicina (B Aires); 1979; 39 Suppl 1():87-99. PubMed ID: 45034
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
    Lebrec D
    Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of beta adrenergic blocking drugs: a growing spectrum.
    Ram CV
    Heart Lung; 1979; 8(1):116-23. PubMed ID: 32152
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta blockers in portal hypertension--current status.
    Koshy A
    Trop Gastroenterol; 1989; 10(3):142-7. PubMed ID: 2573188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse CNS-effects of beta-adrenoceptor blockers.
    Gleiter CH; Deckert J
    Pharmacopsychiatry; 1996 Nov; 29(6):201-11. PubMed ID: 8956349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the psychopharmacology of beta adrenergic blockade.
    Greenblatt DJ; Shader RI
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):615-25. PubMed ID: 4404445
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of beta blockade on the peripheral manifestations of thyrotoxicosis.
    Grossman W; Robin NI; Johnson LW; Brooks H; Selenkow HA; Dexter L
    Ann Intern Med; 1971 Jun; 74(6):875-9. PubMed ID: 4397168
    [No Abstract]   [Full Text] [Related]  

  • 20. [Delirium tremens--a noradenaline-induced stress syndrome treated with alpha and beta blockaders].
    Jessen K; Risbo A; Steptoe P
    Ugeskr Laeger; 1979 Mar; 141(12):798-800. PubMed ID: 34251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.